Aldevron

Aldevron, one of the nation's leading contract service providers of plasmid DNA, proteins, mRNA and antibodies to the biotech industry; has expanded its leadership team by appointing Mike Busch as Vice President of Human Resources.

Aldevron, a leading global provider of plasmid DNA and mRNA manufacturing, protein production and antibody discovery services, and Odylia, a nonprofit organization working to develop treatments for ultra-rare ocular diseases using gene therapy, have...

Area organizations Aldevron, Sanford Health, and North Dakota State University (NDSU) have joined forces to bring together a special event titled, "From the Valley to the Mountain: The RARE Impact of the Red River Valley," on Wednesday, April 11 from...

Aldevron, a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services, is a sponsor for the Rare Disease Day program, "Gene Therapy for Rare Diseases: Promise and Challenges", presented by the University of...

Aldevron, a leading global provider of contract plasmid DNA manufacturing, protein production, and antibody discovery services, announces the availability of GMP-grade SpCas9 nuclease for use in clinical development programs.

Aldevron, a global provider of plasmid DNA and gene editing enzymes used to support novel cancer therapies, will be a Platinum sponsor of the 2017 Believe Ball organized by the Emily Whitehead Foundation.

Henry Hebel has been named Chief Operating Officer of Aldevron, a leading global provider of contract plasmid DNA manufacturing, protein production and antibody discovery services.

Aldevron to produce minicircles to support cell therapy applications

Aldevron, a leading biotechnology contract manufacturing and development organization, is now using a 30-liter single-use fermentation system for manufacturing nucleic acids and proteins.